Eton Pharmaceuticals, Inc. ETON Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $86.93M+79.9% | $79.95M+105% | $70.32M+103% | $58.18M+85.4% | $48.33M+40.9% | ||
| $39.32M+96.0% | $37.21M+139% | $34.2M+142% | $23.62M+85.7% | $20.06M+73.2% | ||
| $47.61M+68.5% | $42.74M+82.6% | $36.12M+75.6% | $34.56M+85.2% | $28.27M+24.4% | ||
| 54.8%-3.7pp | 53.5%-6.6pp | 51.4%-7.9pp | 59.4%-0.1pp | 58.5%-7.8pp | ||
| $8.48M— | $7.77M— | —— | —— | —— | ||
| $37.1M+38.6% | $35.82M+57.4% | $33.68M+63.4% | $30.86M+57.0% | $26.77M+42.8% | ||
| $45.57M+49.3% | $43.58M+67.6% | $38.8M+50.5% | $35.37M+41.8% | $30.53M+37.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | -$6.48M-22.2% | -$4.03M+36.9% | -$4.5M-488% | ||
| —— | —— | $199K+13.7% | $101K-66.4% | $89K-64.0% | ||
| —— | —— | -$6.68M-21.9% | -$4.13M+38.3% | -$4.58M-602% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s revenue?
- Eton Pharmaceuticals, Inc. (ETON) generated $86.9M in revenue over the trailing twelve months, up 79.9% year over year.
- Is Eton Pharmaceuticals, Inc. profitable?
- Eton Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $4.5M over the trailing twelve months, a -9.5% net margin.
- What are Eton Pharmaceuticals, Inc.'s profit margins?
- Gross margin is 54.8% and operating margin is -15.1%, with a -9.5% net margin.
- What is Eton Pharmaceuticals, Inc.'s earnings per share?
- Eton Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-0.06.
- Where does Eton Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
